Abdominal multivisceral transplantation

Satoru Todo, Andreas Tzakis, Kareem Abu-Elmagd, Jorge Reyes, Hiroyuki Furukawa, Bakr Nour, John Fung, Anthony Demetris, Thomas E. Starzl

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Under FK506-based immunosuppression, 13 abdominal multivisceral transplantations were performed in 6 children and 7 adults. Of the 13 recipients, 7 (53.8%) are alive and well with functioning grafts after 9 to 31 months. Six recipients died: Three from PTLD, one from rejection, one from sepsis, and one from respiratory failure. In addition to rejection, postoperative complications occurring in more than isolated cases included PTLD (n=6), abdominal abscess formation (n=5), pancreatitis (n=3), and ampullary dysfunction (n=2). In addition, infection by enteric microorganisms was common during the early postoperative period. Currently, all 7 survivors are on an oral diet and have normal liver function. Two recipients (one insulin-dependent) require antidiabetes treatment, in one case following distal pancreatectomy and in the other after two episodes of pancreatic rejection. Thus, abdominal multivisceral transplantation is a difficult but feasible operation that demands complex and prolonged posttransplantation management. It is not yet ready for application and awaits a better strategy of immune modulation.

Original languageEnglish
Pages (from-to)234-240
Number of pages7
JournalTransplantation
Volume59
Issue number2
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Transplantation
Abdominal Abscess
Pancreatectomy
Tacrolimus
Postoperative Period
Respiratory Insufficiency
Pancreatitis
Immunosuppression
Sepsis
Insulin
Diet
Transplants
Liver
Infection
Therapeutics

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Todo, S., Tzakis, A., Abu-Elmagd, K., Reyes, J., Furukawa, H., Nour, B., ... Starzl, T. E. (1995). Abdominal multivisceral transplantation. Transplantation, 59(2), 234-240.

Abdominal multivisceral transplantation. / Todo, Satoru; Tzakis, Andreas; Abu-Elmagd, Kareem; Reyes, Jorge; Furukawa, Hiroyuki; Nour, Bakr; Fung, John; Demetris, Anthony; Starzl, Thomas E.

In: Transplantation, Vol. 59, No. 2, 1995, p. 234-240.

Research output: Contribution to journalArticle

Todo, S, Tzakis, A, Abu-Elmagd, K, Reyes, J, Furukawa, H, Nour, B, Fung, J, Demetris, A & Starzl, TE 1995, 'Abdominal multivisceral transplantation', Transplantation, vol. 59, no. 2, pp. 234-240.
Todo S, Tzakis A, Abu-Elmagd K, Reyes J, Furukawa H, Nour B et al. Abdominal multivisceral transplantation. Transplantation. 1995;59(2):234-240.
Todo, Satoru ; Tzakis, Andreas ; Abu-Elmagd, Kareem ; Reyes, Jorge ; Furukawa, Hiroyuki ; Nour, Bakr ; Fung, John ; Demetris, Anthony ; Starzl, Thomas E. / Abdominal multivisceral transplantation. In: Transplantation. 1995 ; Vol. 59, No. 2. pp. 234-240.
@article{5a51899b050044c2bb00f2252ac4994b,
title = "Abdominal multivisceral transplantation",
abstract = "Under FK506-based immunosuppression, 13 abdominal multivisceral transplantations were performed in 6 children and 7 adults. Of the 13 recipients, 7 (53.8{\%}) are alive and well with functioning grafts after 9 to 31 months. Six recipients died: Three from PTLD, one from rejection, one from sepsis, and one from respiratory failure. In addition to rejection, postoperative complications occurring in more than isolated cases included PTLD (n=6), abdominal abscess formation (n=5), pancreatitis (n=3), and ampullary dysfunction (n=2). In addition, infection by enteric microorganisms was common during the early postoperative period. Currently, all 7 survivors are on an oral diet and have normal liver function. Two recipients (one insulin-dependent) require antidiabetes treatment, in one case following distal pancreatectomy and in the other after two episodes of pancreatic rejection. Thus, abdominal multivisceral transplantation is a difficult but feasible operation that demands complex and prolonged posttransplantation management. It is not yet ready for application and awaits a better strategy of immune modulation.",
author = "Satoru Todo and Andreas Tzakis and Kareem Abu-Elmagd and Jorge Reyes and Hiroyuki Furukawa and Bakr Nour and John Fung and Anthony Demetris and Starzl, {Thomas E.}",
year = "1995",
language = "English",
volume = "59",
pages = "234--240",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Abdominal multivisceral transplantation

AU - Todo, Satoru

AU - Tzakis, Andreas

AU - Abu-Elmagd, Kareem

AU - Reyes, Jorge

AU - Furukawa, Hiroyuki

AU - Nour, Bakr

AU - Fung, John

AU - Demetris, Anthony

AU - Starzl, Thomas E.

PY - 1995

Y1 - 1995

N2 - Under FK506-based immunosuppression, 13 abdominal multivisceral transplantations were performed in 6 children and 7 adults. Of the 13 recipients, 7 (53.8%) are alive and well with functioning grafts after 9 to 31 months. Six recipients died: Three from PTLD, one from rejection, one from sepsis, and one from respiratory failure. In addition to rejection, postoperative complications occurring in more than isolated cases included PTLD (n=6), abdominal abscess formation (n=5), pancreatitis (n=3), and ampullary dysfunction (n=2). In addition, infection by enteric microorganisms was common during the early postoperative period. Currently, all 7 survivors are on an oral diet and have normal liver function. Two recipients (one insulin-dependent) require antidiabetes treatment, in one case following distal pancreatectomy and in the other after two episodes of pancreatic rejection. Thus, abdominal multivisceral transplantation is a difficult but feasible operation that demands complex and prolonged posttransplantation management. It is not yet ready for application and awaits a better strategy of immune modulation.

AB - Under FK506-based immunosuppression, 13 abdominal multivisceral transplantations were performed in 6 children and 7 adults. Of the 13 recipients, 7 (53.8%) are alive and well with functioning grafts after 9 to 31 months. Six recipients died: Three from PTLD, one from rejection, one from sepsis, and one from respiratory failure. In addition to rejection, postoperative complications occurring in more than isolated cases included PTLD (n=6), abdominal abscess formation (n=5), pancreatitis (n=3), and ampullary dysfunction (n=2). In addition, infection by enteric microorganisms was common during the early postoperative period. Currently, all 7 survivors are on an oral diet and have normal liver function. Two recipients (one insulin-dependent) require antidiabetes treatment, in one case following distal pancreatectomy and in the other after two episodes of pancreatic rejection. Thus, abdominal multivisceral transplantation is a difficult but feasible operation that demands complex and prolonged posttransplantation management. It is not yet ready for application and awaits a better strategy of immune modulation.

UR - http://www.scopus.com/inward/record.url?scp=0028860208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028860208&partnerID=8YFLogxK

M3 - Article

VL - 59

SP - 234

EP - 240

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 2

ER -